About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT06993324

Awareness of Families With Down Syndrome Children About the Role of Physical Therapy in Egypt

This study explores how much families with children who have Down Syndrome in Egypt know about the benefits and role of physical therapy. By understanding their awareness, hope to improve education an...

Lead sponsor: Cairo University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Cairo University

This cross-sectional study aims to assess the awareness of families with children who have Down Syndrome regarding the role of physical therapy in Egypt. Data will be collected via a validated questionnaire distributed to family members to evaluate their knowledge and perceptions about physical therapy interventions. The study seeks to identify gaps in awareness and inform strategies for improving educational outreach and support for these families.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Parents/guardians of children diagnosed with DS.
•Egyptian residents.
•Consent to participate in the study
•Aged 18 years or older

Exclusion Criteria

•Families with children who have conditions other than DS.
•Participants who do not provide informed consent.

Related studies

RECRUITINGPhase 3

Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome

NCT07135167 · Down Syndrome (DS), Keratoconus, and more

Effects of Chronic Creatine and Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Oxidative Stress, Inflammation, Muscle Strength, and Body Composition in Individuals With Down Syndrome

NCT07213063 · Down Syndrome (DS), Supplementation

RECRUITINGPhase 3

LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

NCT07234695 · Down Syndrome, Down Syndrome (DS), and more

Using Technologies to Promote HEalthy Lifestyles in Adolescents With Intellectual Disabilities

NCT07101523 · Intellectual Disabilities (F70-F79), Down Syndrome (DS), and more

Not Yet RecruitingPhase 4

Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation

NCT06911944 · Down Syndrome (DS), Down Syndrome (Trisomy 21), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 8, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment240

Start dateApr 2025

Last updatedSep 8, 2025

Condition

Down Syndrome (DS)

Locations shown

Faculty of Physical Therapy, Cairo University

Giza, Cairo Governorate

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 8, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions